[1] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2018版)[J/CD]. 新发传染病电子杂志,2019,4(2):65-84. [2] ENGELS EA, PFEIFFER RM, GOEDERT JJ, et al., Trends in cancer risk among people with AIDS in the United States 1980-2002[J]. AIDS, 2006, 20(12): 1645-1654. [3] ROBBINS HA, YAN LI, CAROLINA P, et al.Epidemiologic contributions to recent cancer trends among HIV-infected people in United States[J]. AIDS, 2014, 28(6): 881-890. [4] ZLOTORZYNSKA M,SPAULDING AC,MESSINA LC,et al.Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era[J]. BMJ Open, 2016, 6(4): 1-5. [5] PARK LS,TATE JP,SIGEL K,et al.Time trends in cancer incidence in persons living with AIDS in the antiretroviral therapy era: 1997-2012[J]. AIDS, 2016, 30(11): 1795-1806. [6] CALABRESI A,FERRARESI A,FESTA A,et al.Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009[J]. HIV Med, 2013, 14(8):481-490. [7] SHIELS MS, COLE SR, KIRK GD, et al.A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals[J]. J Acquir Immune Defic Syndr, 2009, 52(5): 611-622. [8] 曹鸣菲,雷德财,宋晓玉,等. 四川省肿瘤医院2005~2018年肿瘤住院患者HIV抗体筛查结果分析[J]. 医学信息, 2019, 32(7):82-85. [9] 甘清鑫,刘晋新. 艾滋病合并恶性肿瘤[J/CD]. 新发传染病电子杂志,2016,1(1):53-55. [10] 黄曦阮,石明巧,苟瑜,等. 64例艾滋病患者合并肿瘤临床特征分析[J]. 四川医学,2018,39(7):743-747. [11] 李秋林,曹冀,容敏华,等. 2016年广西肿瘤登记地区恶性肿瘤发病和死亡分析[J]. 中国癌症防治杂志, 2020,12(1):44-51. [12] 夏西超,黄耀平,刘洋,等. 4例艾滋病合并肝脏肿瘤患者的影像学和病理学分析[J]. 社区医学杂志,2018,16(5):26-29. [13] 覃江龙,卢亦波,秦英梅,等. 艾滋病伴发皮肤损害的皮肤病理学分析[J].中国热带医学,2020,20(1):77-80. [14] 黄德扬,刘晋新,张烈光,等. HIV/AIDS合并肺癌的CT表现分析[J]. 中国CT和MRI杂志,2019,17(1):81-83. [15] 刘勇刚,鲍诗平. 艾滋病相关耳鼻咽喉头颈部卡波西肉瘤六例临床分析[J]. 海南医学,2018,29(15):2170-2172. [16] 马良,苏丹柯,肖晓兰,等. 广西壮族自治区某肿瘤医院2007年-2016年恶性肿瘤住院患者疾病谱分析[J]. 中国病案, 2018,19(5):62-66. |